These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12917205)

  • 1. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.
    Probst-Hensch NM; Wang H; Goh VH; Seow A; Lee HP; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):739-46. PubMed ID: 12917205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States).
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Causes Control; 2005 Oct; 16(8):917-27. PubMed ID: 16132801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
    Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating insulin-like growth factor-related biomarkers: Correlates and responses to calcium supplementation in colorectal adenoma patients.
    Um CY; Fedirko V; Flanders WD; Höflich C; Wirthgen E; Bostick RM
    Mol Carcinog; 2017 Sep; 56(9):2127-2134. PubMed ID: 28467661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): A large-scale cross-sectional study in the Japan Collaborative Cohort study.
    Wakai K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():23-7. PubMed ID: 20553077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
    Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-fat diet with omega-3 fatty acids increases plasma insulin-like growth factor concentration in healthy postmenopausal women.
    Young LR; Kurzer MS; Thomas W; Redmon JB; Raatz SK
    Nutr Res; 2013 Jul; 33(7):565-71. PubMed ID: 23827131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants.
    Smith WJ; Underwood LE; Keyes L; Clemmons DR
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3982-8. PubMed ID: 9398700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.